Package Leaflet: Information for the Patient
Loxifan 2.5mg film-coated tablets
Letrozole
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
What is Loxifan and how does it work
Loxifan contains the active substance letrozole. It belongs to a group of medicines called aromatase inhibitors. It is a hormonal (or "endocrine") treatment for breast cancer. The growth of breast cancer is usually stimulated by estrogens, which are female sex hormones. Loxifan reduces the amount of estrogen by blocking an enzyme (aromatase) involved in estrogen production, and thus can block the growth of breast cancers that need estrogens to grow. As a result, tumor cells grow more slowly or stop growing and/or spreading to other parts of the body.
What is Loxifan used for
Loxifan is used to treat breast cancer in women who have gone through the menopause, i.e., the cessation of menstrual periods.
It is used to prevent breast cancer from coming back. It can be used as the first treatment before breast cancer surgery, if surgery is not immediately possible, or it can be used as the first treatment after breast cancer surgery, or after five years of treatment with tamoxifen. Loxifan is also used to prevent the breast tumor from spreading to other parts of the body in patients with advanced breast cancer.
If you have any questions about how Loxifan works or why you have been prescribed this medicine, ask your doctor.
Follow carefully all instructions given to you by your doctor. They may differ from the general information contained in this leaflet.
Do not take Loxifan
If any of these cases apply to you, do not take this medicine and inform your doctor.
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting treatment with Loxifan:
If any of these cases apply to you, inform your doctor. Your doctor will take this into account during your treatment with Loxifan.
Letrozole may cause tendon inflammation or tendon damage (see section 4). If you experience any signs of pain or inflammation of the tendons, rest the affected area and contact your doctor.
Children and adolescents (under 18 years)
Children and adolescents should not use this medicine.
Elderly patients (65 years and over)
People aged 65 and over can use this medicine at the same dose as for adults.
Other medicines and Loxifan
Tell your doctor or pharmacist that you are taking, have recently taken, or might take any other medicines, including those without a prescription.
Pregnancy, breastfeeding, and fertility
Driving and using machines
If you feel dizzy, tired, sleepy, or unwell, do not drive or operate tools or machines until you feel better.
Loxifan contains lactose and sodium
If your doctor has told you that you have an intolerance to some sugars, consult with them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Use in athletes
This medicine contains letrozole, which may produce a positive result in doping tests.
Follow exactly the instructions for administration of this medicine given to you by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The usual dose is one Loxifan tablet once a day. If you take Loxifan at the same time every day, it will help you remember when to take the tablet.
The tablet can be taken with or without food and should be swallowed whole with a glass of water.
How long to take Loxifan
Continue taking Loxifan every day for the time your doctor tells you. You may need to take it for months or even years. If you have any doubts about how long you should take Loxifan, consult your doctor.
Monitoring of treatment with Loxifan
You should only take this medicine under strict medical supervision. Your doctor will periodically check your condition to ensure that the treatment has the desired effect.
Loxifan may cause a decrease in bone thickness or bone loss (osteoporosis) due to the decrease in estrogen in the body. Your doctor may decide to perform bone density measurements (a way to check for osteoporosis) before, during, and after treatment.
If you take more Loxifan than you should
If you have taken too many Loxifan tablets, or if someone else has taken your tablets, contact your doctor or go to the hospital immediately. Show them the pack of tablets. You may need medical treatment. You can also call the Toxicology Information Service, Tel: 915620420, indicating the medicine and the amount taken.
If you forget to take Loxifan
If you stop taking Loxifan
Do not stop taking Loxifan unless your doctor tells you to. See also the section "How long to take Loxifan".
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Most side effects are mild to moderate and usually disappear after a few days or weeks of treatment.
Some of these side effects, such as hot flashes, hair loss, or vaginal bleeding, may be due to the lack of estrogen.
Do not be alarmed by this list of possible side effects. You may not experience any of them.
Some side effects can be serious:
Uncommon(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
If you experience any of the above, inform your doctor immediately.
You should also inform your doctor immediately if you experience any of the following symptoms during treatment with Loxifan:
Some side effects are very common(may affect more than 1 in 10 people):
If any of these side effects bother you seriously, consult your doctor.
Some side effects are common(may affect up to 1 in 10 people):
If any of these side effects bother you seriously, inform your doctor.
Some side effects are uncommon(may affect up to 1 in 100 people):
Side effects with unknown frequency(cannot be estimated from available data):
Trigger finger, a condition where your finger or thumb gets stuck in a bent position.
If any of these side effects bother you seriously, inform your doctor.
Reporting of side effects
If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the Spanish Medicines Agency's website: www.notificaRAM.es. By reporting side effects, you can help provide more information on the safety of this medicine.
What Loxifan contains
Appearance and packaging
Marketing authorization holder
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 – Barcelona, Spain
Manufacturer
Novartis Farmacéutica, S.A.
Gran Via de les Corts Catalanes, 764
08013 Barcelona, Spain
or
NOVARTIS PHARMA GMBH
Roonstrasse 25 (Nuremberg) - D-90429 - Germany
or
NOVARTIS PHARMA, S.A.S.
8-10 Rue Henri Sainte-Claire Deville Rueil Malmaison - F-92500 - France
or
SALUTAS PHARMA GMBH
Otto Von Guericke Alle, 1 (Barleben) - D-39179 - Germany
or
NOVARTIS SVERIGE AB
Torshamnsgatan 48, 164 40 Kista, Sweden
or
NOVARTIS FINLAND OY
Metsanneidonkujaq (Espoo) - FIN-02130 - Finland
or
NOVARTIS HUNGARIA KFT.
Bartok Bela ut 43-47 (Budapest) - 1114 - Hungary
or
NOVARTIS PHARMA GMBH
Jakov-Lind-Straβe 5, Top 3.05, 1020 Wien - Austria
or
NOVARTIS PHARMA BV
Haaksbergweg 16, 1101 BX Amsterdam - Netherlands
or
NOVARTIS FARMA S.P.A.
Via Provinciale Schito 131 (Torre Annunziata) - 80058 - Italy
or
NOVARTIS PHARMA NV/SA
Medialaan, 40 (Vilvoorde) - B-1800 - Belgium
or
NOVARTIS HEALTHCARE A/S
Edvard Thomsens Vej 14,3. (Copenhagen) - DK-2300 - Denmark
or
NOVARTIS SRO
Na Pankraci 1724/129 Nusle (Prague) - 14000 - Czech Republic
or
NOVARTIS FARMA-PRODUCTOS FARMACEUTICOS, S.A.
Avenida Professor Doutor Cavaco Silva, nº 10E (Taguspark, Porto Salvo) - 2740-255 – Portugal
or
NOVARTIS (HELLAS) S.A.
12th Km National Road Athinon-Lamias, Metamorphosis Attiki - 14451 - Greece
or
Novartis Pharma GmbH
Sophie-Germain-Strasse 10, Nuremberg 90443, Germany
or
NOVARTIS FARMA S.P.A.
Viale Luigi Sturzo 43, 20154, Milan (MI), Italy
This medicine is authorized in the Member States of the European Economic Area under the following names:
Member State | Medicine name |
Denmark, Finland, Iceland, and Norway | Femar |
Austria, Belgium, Bulgaria, Croatia, Cyprus, Spain, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Portugal, Slovenia, Netherlands | Femara |
Date of last revision of this leaflet:November/2020
Other sources of information
Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS)
http://www.aemps.gob.es/